Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex dose-finding in uterine fibroids and endometriosis
NCT01187043Phase 2Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- Aug 2010
- Primary completion
- Mar 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in Uterine Fibroids (UF), endometriosis, Menorrhagia, sponsored by Repros Therapeutics Inc.. Started Aug 2010; status: completed.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)endometriosisMenorrhagia
Beyond the preview
Go deeper on NCT01187043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187043.